- Home
- GTBP vs INBS Comparison
GTBP vs INBS Comparison
Compare GTBP & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- INBS
- Stock Information
- Founded
- GTBP 1965
- INBS 2016
- Country
- GTBP United States
- INBS United States
- Employees
- GTBP N/A
- INBS N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- GTBP Health Care
- INBS Health Care
- Exchange
- GTBP Nasdaq
- INBS Nasdaq
- Market Cap
- GTBP 6.6M
- INBS 6.3M
- IPO Year
- GTBP N/A
- INBS N/A
- Fundamental
- Price
- GTBP $2.13
- INBS $1.29
- Analyst Decision
- GTBP Strong Buy
- INBS
- Analyst Count
- GTBP 1
- INBS 0
- Target Price
- GTBP $11.00
- INBS N/A
- AVG Volume (30 Days)
- GTBP 22.2K
- INBS 115.2K
- Earning Date
- GTBP 11-14-2024
- INBS 02-07-2025
- Dividend Yield
- GTBP N/A
- INBS N/A
- EPS Growth
- GTBP N/A
- INBS N/A
- EPS
- GTBP N/A
- INBS N/A
- Revenue
- GTBP N/A
- INBS $3,187,974.00
- Revenue This Year
- GTBP N/A
- INBS $280.88
- Revenue Next Year
- GTBP N/A
- INBS $126.26
- P/E Ratio
- GTBP N/A
- INBS N/A
- Revenue Growth
- GTBP N/A
- INBS 55.29
- 52 Week Low
- GTBP $1.92
- INBS $1.00
- 52 Week High
- GTBP $10.66
- INBS $11.70
- Technical
- Relative Strength Index (RSI)
- GTBP 40.32
- INBS 40.01
- Support Level
- GTBP $2.41
- INBS $1.36
- Resistance Level
- GTBP $3.40
- INBS $1.69
- Average True Range (ATR)
- GTBP 0.30
- INBS 0.10
- MACD
- GTBP -0.04
- INBS -0.03
- Stochastic Oscillator
- GTBP 6.09
- INBS 11.11
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).